Flexible Digital Video Cystoscopes Market Scope
Flexible digital video cystoscopes use visual fibers to carry images from the scope tip to the eyepiece, generating images that normally have a pixilated screen door effect. The flexible video cystoscope provides a number of key features and improved functionality to office-based and hospital urologists. The flexible digital video cystoscope are used with the hospitalís existing video system. The efficient quality of the Flexible Video Cystoscope provides important advantages over more traditional technologies. Cystoscopes with distal sensor technology improve visibility in a simulated challenging working environment associated with fiberoptic cystoscopes.
The market study is being classified by Type (Reusable Flexible Digital Video Cystoscopies and Single-Use Cystoscope), by Application (Urology and Gynaecology) and major geographies with country level break-up.
Research Analyst at AMA predicts that German Players will contribute to the maximum growth of Global Flexible Digital Video Cystoscopes market throughout the predicted period.
NeoScope Inc. (United States), Coloplast Group (Denmark), Stryker Corporation (United States), MOSS S.p.A (Italy), Richard Wolf GmbH (Germany), Maxer Endoscopy GmbH (Germany), PENTAX Medical (Japan), OPTEC Endoscopy Systems GmbH (Germany), FUJIFILM Corporation (Japan), Boston Scientific Corporation (United States), Olympus Corporation (Japan) and KARL STORZ SE & Co. KG (Germany) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are LABORIE (United States) and Mindhao Medical Technology (China).
AdvanceMarketAnalytics has segmented the market of Global Flexible Digital Video Cystoscopes market by Type, Application and Region.
On the basis of geography, the market of Flexible Digital Video Cystoscopes has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
December 23, 2019- Boston Scientific Corporation announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the EXALT Model D Single-Use Duodenoscope for use in endoscopic retrograde cholangiopancreatography (ERCP) procedures.
Introducing a device into commercial distribution for the first time. After May 28, 1976 (effective date of the Medical Device Amendments to the Act), anyone who wants to sell a device in the U.S. is required to make a 510(k) submission at least 90 days prior to offering the device for sale, even though it may have been under development or clinical investigation before that date. If your device was not marketed by your firm before May 28, 1976, a 510(k) is required.
- Technological Advancement in Visualization Is Driving This Market
- Increase in the Number of Elderly People Who Are At Risk to Gastrointestinal
- Increase in Consumer Preference for Minimally Invasive Surgeries
- Growth in Geriatric Population, Obesity, and Changes in Demographics & Lifestyle
- High-Cost Associated With Cystoscopy
- Increasing risk of Post-Operative Infections
- High Cost Become the Barrier in This Industry
Key Target Audience
Manufacturers of Flexible Digital Video Cystoscopes, Suppliers of Flexible Digital Video Cystoscopes, Wholesalers, Distributors and Retailers of Flexible Digital Video Cystoscopes, Healthcare Industry and Regulatory Bodies
Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase